Abstract: In one embodiment of the present invention, a method is provided for assisting cartilage diagnostic and therapeutic procedures and includes the steps of acquiring 3D osteocartilaginous parameters by using multimodal 3D tracked devices; incorporating these parameters into a volumic anatomic osteocartilaginous model from which a bone tracking virtual real-time environment is built; three-dimensionally computing an osteocartilaginous quality score from this multiparametric 3D osteocartilaginous model; providing real-time navigation in this 3D virtual environment in order to make ongoing therapeutic assessments and adjustments; and updating steps 1 to 3 according to the performed therapy. It will be appreciated that the above steps are compatible with arthroscopic procedures involving cartilage.

Abstract: The use of a peptide reagent for detecting the presence or absence of a primary Epstein-Barr virus infection in a patient by testing for IgM antibodies, recognizing said reagent, in a biological sample from the patient according to a per se known method based on the formation of at least one antigen-antibody complex, is disclosed. The reagent contains a peptide recognized by at least one antibody to a peptide having the sequence of formula (II): Leu Glu Ile Lys Arg Tyr Lys Asn Arg Val Ala Ser Arg Lys Cys Arg Ala Lys Phe Lys Gln. The reagent enables such a primary infection to be detected very early.